Chester County News and Community Website
CHESTERBROOK, PA — Biopharmaceutical company Trevena, Inc. (NASDAQ: TRVN) has reported its Q3 2023 financial results, shedding light on a net loss attributable to common stockholders of $7.9 million, or …
Trevena Reports Promising Q3 2023 Results, Reveals Progress in TRV045 Studies and OLINVYK Sales Read More
MALVERN, PA — Cantaloupe, Inc. (NASDAQ: CTLP), a leading provider of technology solutions for self-service commerce, recently reported its financial results for the first quarter of fiscal year 2024, ending …
Cantaloupe, Inc. Reports Strong First Quarter Fiscal Year 2024 Results Amid Global Expansion Read More
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) recently announced its third-quarter financial results ending September 30, 2023, and provided a corporate update that includes the completion of a significant merger …
Immunome Merges with Morphimmune, Secures $125M in Funding for Accelerated Cancer Therapy Development Read More
BERWYN, PA — Envestnet (NYSE: ENV), a leading provider of intelligent systems for wealth management and financial wellness, recently announced its financial results for the third quarter and nine months …
Envestnet Reports Q3 2023 Financial Results: Revenue Increases and Net Income Rebounds Read More
EXTON, PA — Bentley Systems, Incorporated (NASDAQ: BSY), a leading global provider of comprehensive software solutions for advancing infrastructure, has recently announced its operating results for the third quarter and …
Bentley Systems Reports Strong Third Quarter 2023 Operating Results with 14.3% Revenue Growth Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leading player in the biotechnology industry, recently reported its financial results for the third quarter of 2023, marking an impressive 11th …
TELA Bio Reports Q3 2023 Results: 11th Consecutive Quarter of 35% YoY Growth Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA recently announced financial results for the third quarter ended September 30, 2023.
Verrica Pharmaceuticals Reports Third Quarter 2023 Financial Results Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a frontrunner in the world of biopharmaceuticals, recently disclosed its Q3 2023 financial results and a business update that holds promising news for …
Ocugen’s Promising Advancements: Q3 2023 Financial Results and Progress in Ophthalmic Gene Therapies, Regenerative Cell Therapies, and Vaccines Portfolio Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) recently released its financial results for the third quarter ending September 30, 2023, and announced its strategic acquisition of Newport wafer fab …
Vishay Intertechnology Reports Q3 2023 Results, Announces Acquisition of Newport Wafer Fab Read More
BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS) recently announced third quarter financial results for the period ended September 30, 2023, and reviewed recent accomplishments.
Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate Update Read More